Programmable Photoswitchable Microcapsules Enable Precise and Tailored Drug Delivery from Microfluidics

• Published in: ACS applied materials & interfaces Vol. 16; no. 5; pp. 6447 - 6461
• Main Authors: Guo, Buyun, Chen, Tianao, Hu, Xianglong, Yang, Chen, Shi, Zhengdi, Wang, Zhaojun, Wu, Xizhi, Shen, Shuwei, Ding, Weiping, Huang, Fangsheng, Zhu, Zhiqiang, Xu, Ronald X.
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 07-02-2024
• Subjects: Applications of Polymer, Composite, and Coating Materials; controlled release; photoswitchable; embolization; microfluidics; multifunctional microcapsules
• ISSN: 1944-8244; 1944-8252
• DOI: 10.1021/acsami.3c17621

The development of precision personalized medicine poses a significant need for the next generation of advanced diagnostic and therapeutic technologies, and one of the key challenges is the development of highly time-, space-, and dose-controllable drug delivery systems that respond to the complex physiopathology of patient populations. In response to this challenge, an increasing number of stimuli-responsive smart materials are integrated into biomaterial systems for precise targeted drug delivery. Among them, responsive microcapsules prepared by droplet microfluidics have received much attention. In this study, we present a UV-visible light cycling mediated photoswitchable microcapsule (PMC) with dynamic permeability-switching capability for precise and tailored drug release. The PMCs were fabricated using a programmable pulsed aerodynamic printing (PPAP) technique, encapsulating an aqueous core containing magnetic nanoparticles and the drug doxorubicin (DOX) within a poly­(lactic-co-glycolic acid) (PLGA) composite shell modified by PEG-b-PSPA. Selective irradiation of PMCs with ultraviolet (UV) or visible light (Vis) allows for high-precision time-, space-, and dose-controlled release of the therapeutic agent. An experimentally validated theoretical model was developed to describe the drug release pattern, holding promise for future customized programmable drug release applications. The therapeutic efficacy and value of patternable cancer cell treatment activated by UV radiation is demonstrated by our experimental results. After in vitro transcatheter arterial chemoembolization (TACE), PMCs can be removed by external magnetic fields to mitigate potential side effects. Our findings demonstrate that PMCs have the potential to integrate embolization, on-demand drug delivery, magnetic actuation, and imaging properties, highlighting their immense potential for tailored drug delivery and embolic therapy.